Stefaniak, M. et al. 2022. Eslicarbazepine acetate: An efficacy and safety as an antiepileptic drug in clinical trials and open studies. Journal of Education, Health and Sport. 12, 2 (Feb. 2022), 16–26. DOI:https://doi.org/10.12775/JEHS.2022.12.02.002.